Wave Life Sciences Ltd.

NASDAQ:WVE

Biotechnology

Healthcare
$2.77 +1.63%

+$0.10 today

Market cap
$546.32M
Beta
-1.33
P/E (TTM)
-6.6
EPS (TTM)
-$0.92
52W Low $5.02High $21.73

Volume 2.21M

Average 4.86M

WVE Pre-Tax Margin

Income before tax as a percentage of revenue.

Wave Life Sciences Ltd.NASDAQ: WVE

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to -68.2%

Pre-tax margin was -68.2% in Q1 FY2026, up 442.7 pp from a year earlier. On a trailing-twelve-month basis it was -255.7%, down 148.7 pp year over year. Over 3 fiscal years it widened by 3937.7 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-68.2%+240.2 pp QoQ
Last fiscal yearDec 2025
-478.3%-388.8 pp YoY
LTMMar 2026
-255.7%-148.7 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+442.7 pp——
1 year-388.8 pp——
3 years+3937.7 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-478.3%
Year-over-year change
-388.8pp

Pre-Tax Margin vs competitors

How WVE compares with its peers on the latest reported figures

  • WVE's LTM Mar 2026 pre-tax margin of -255.7% is the 6th highest of the 10 companies compared; the peer median is -173.5%.
  • Its year-over-year change of -148.7 pp is the 6th highest of 9, against a peer median of -76.3 pp.
  • Over three fiscal years its change of +3937.7 pp compares with a peer median of +42.0 pp.
WVE Competitors Peer median
Pre-Tax Margin for WVE and competitors
Company Period LTM level YoY 3-year change
ALNYAlnylam Pharmaceuticals, Inc.LTM Jun 202616.6% +32.1 pp+117.3 pp
SRPTSarepta Therapeutics, Inc.LTM Mar 20261.1% +8.5 pp+42.0 pp
IONSIonis Pharmaceuticals, Inc.LTM Sep 2026-56.7% -29.9 pp+3.7 pp
ARWRArrowhead Pharmaceuticals, Inc.LTM Sep 2026-160.6% -166.8 pp-74.8 pp
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026-173.5% -122.7 pp-103.0 pp
WVEWave Life Sciences Ltd.LTM Mar 2026-255.7% -148.7 pp+3937.7 pp
PRQRProQR Therapeutics N.V.LTM Mar 2026-339.3% -179.1 pp+1518.7 pp
STOKStoke Therapeutics, Inc.LTM Mar 2026-533.2% -560.2 pp+811.0 pp
NTLAIntellia Therapeutics, Inc.LTM Mar 2026-597.0% +557.1 pp+299.9 pp
SLNSilence Therapeutics plcLTM Mar 2026-9241.5% —-15620.7 pp
BNTCBenitec Biopharma Inc.FY2025— ——
Peer median (excluding WVE) -173.5%-76.3 pp+42.0 pp

Competitors are the stored peer set for WVE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue40.96M3.65M113.31M108.3M42.73M
Cost of Revenue00008.85M
Gross Profit40.96M3.65M113.31M108.3M33.88M
Gross Margin100.0%100.0%100.0%100.0%79.3%
Research & Development121.88M115.86M130.01M159.68M182.78M
Selling, General & Admin46.11M50.51M51.29M59.02M75.33M
Operating Expenses167.98M166.37M181.3M218.71M249.26M
Depreciation & Amortization9.84M10.11M9.21M8.66M8.85M
EBITDA(112.61M)(151.03M)(48.98M)(88.35M)(195.53M)
EBITDA Margin-274.9%-4138.9%-43.2%-81.6%-457.6%
Operating Income(127.02M)(162.72M)(68M)(110.4M)(215.38M)
Operating Margin-310.1%-4459.3%-60.0%-101.9%-504.1%
Interest Income30K00010.48M
Interest Expense00000
Other Income / Expenses4.57M1.58M9.81M13.4M11.01M
Income Before Tax(122.45M)(161.14M)(58.19M)(97.01M)(204.38M)
Pre-Tax Margin-298.9%-4416.1%-51.4%-89.6%-478.3%
Income Tax Expense(204K)681K(677K)00
Net Income(122.25M)(161.82M)(57.51M)(97.01M)(204.38M)
Net Margin-298.4%-4434.7%-50.8%-89.6%-478.3%
EPS (Basic)(2.36)(2.05)(0.54)(0.70)(1.21)
EPS (Diluted)(2.36)(2.05)(0.54)(0.70)(1.21)
Weighted Avg Shares51.83M78.86M106.1M138.28M168.65M
Weighted Avg Shares (Diluted)51.83M78.86M106.1M138.28M168.65M

Wave Life Sciences Ltd.

NASDAQ:WVE

Intrinsic Alpha fair value

Locked

Current Price

$2.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.